Accendra Health Q2 revenue down 10%, adjusted loss; CEO Pesicka to retire by end of 2026

ACCENDRA HEALTH INC/VA/

Q2 net revenue $613.2M, down 10% YoY from $681.9M; GAAP EPS -$1.16 vs -$1.09.
Adjusted EBITDA $60.1M vs $96.6M; adjusted EPS -$0.19 vs +$0.26; free cash flow -$25.1M.
Reduced total debt by $385M in Q2 via balance sheet optimization closed in June.
CEO Ed Pesicka to retire by end of 2026; will step down from Board; succession process underway.
Eliminated over $125M annualized operating expense from large commercial payor exit.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.